Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Peng Cheng
Observed names:
Cheng Peng,
Cheng, Peng,
PENG CHENG
Institutions:
Guangxi Medical University,
First Affiliated Hospital of GuangXi Medical University
Observed institutions:
Guangxi Medical University,
Second Military Medical University,
Changhai Hospital,
First Affiliated Hospital of GuangXi Medical University
ORCID:
0000-0003-0716-8124
Observed ORCID:
0000-0003-0716-8124
OpenAlex ID:
A5100700050
Three cases of congenital dysfibrinogenemia in unrelated Chinese families
2016
·
Meiling Luo
, Donghong Deng
, et al.
·
Medicine
·
99
Combined use of Clauss and prothrombin time‐derived methods for determining fibrinogen concentrations: Screening for congenital dysfibrinogenemia
2017
·
Liqun Xiang
, Meiling Luo
, et al.
·
Journal of Clinical Laboratory Analysis
·
47
PDF
Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia
2021
·
Jie Wei
, Xun-Jun Huang
, et al.
·
Annals of Translational Medicine
·
38
PDF
Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia
2021
·
Jie Wei
, Guan Ye Nai
, et al.
·
Annals of Translational Medicine
·
27
PDF
Alterations of anticoagulant proteins and soluble endothelial protein C receptor in thalassemia patients of Chinese origin
2018
·
Yulan Huang
, Yuan Long
, et al.
·
Thrombosis Research
·
25
Liproxstatin‑1 induces cell cycle arrest, apoptosis, and caspase‑3/GSDME‑dependent secondary pyroptosis in K562 cells
2022
·
Hai-Qun Dong
, Shi-Jing Liang
, et al.
·
International Journal of Oncology
·
23
PDF
Dysfibrinogenemia in a patient undergoing artificial abortion after misdiagnosis and review of the literature
2015
·
Jie Yan
, Donghong Deng
, et al.
·
Clinica Chimica Acta
·
16
Guillain-Barré syndrome in a patient with multiple myeloma after bortezomib therapy: A case report
2019
·
Yu-Ling Xu
, Wei-Hua Zhao
, et al.
·
World Journal of Clinical Cases
·
14
PDF
Participation of Proteinase-Activated Receptor-2 in Passive Cutaneous Anaphylaxis-Induced Scratching Behavior and the Inhibitory Effect of Tacrolimus
2009
·
Yu Zhu
, Cheng Peng
, et al.
·
Biological and Pharmaceutical Bulletin
·
14
PDF
Management of dysfibrinogenemia in pregnancy: A case report
2017
·
Jie Yan
, Donghong Deng
, et al.
·
Journal of Clinical Laboratory Analysis
·
13
PDF
Guideline for diagnosis and management of congenital dysfibrinogenemia
2024
·
Jie Yan
, Lin Liao
, et al.
·
Clinica Chimica Acta
·
10
Abnormal fibrinogen with an Aα 16Arg → Cys substitution is associated with multiple cerebral infarctions
2018
·
Meiling Luo
, Aiqiu Wei
, et al.
·
Journal of Thrombosis and Thrombolysis
·
9
A novel mutation in the fibrinogen Aα chain (Gly13Arg, fibrinogen Nanning) causes congenital dysfibrinogenemia associated with defective peptide A release
2016
·
Jie Yan
, Meiling Luo
, et al.
·
International Journal of Hematology
·
9
Fibrinogen Clauss and prothrombin time derived method ratio can differentiate dysfibrinogenemia from hypofibrinogenemia and hyperfibrinogenemia
2020
·
Meiling Luo
, Liqun Xiang
, et al.
·
Thrombosis Research
·
8
A novel fibrinogen gamma-chain mutation, p.Cys165Arg, causes disruption of the γ165Cys–Bβ227Cys disulfide bond and ultimately leads to hypofibrinogenemia
2018
·
WeiJie Zhou
, Meiling Luo
, et al.
·
Thrombosis Research
·
8
Congenital dysfibrinogenemia caused by γAla327Val mutation: structural abnormality of D region
2021
·
Aiqiu Wei
, Yangyang Wu
, et al.
·
Hematology
·
7
PDF
Selection of reference genes in liproxstatin-1-treated K562 Leukemia cells via RT-qPCR and RNA sequencing
2024
·
Hai-Qun Dong
, Xue-Ying Hu
, et al.
·
Molecular Biology Reports
·
5
Analysis of the genetic variants associated with recurrent thromboembolism in a patient with hemoglobin H disease following splenectomy: A case report
2016
·
NA SUN
, PENG CHENG
, et al.
·
Biomedical Reports
·
4
PDF
[Expression of miR-550a-5p in Myelodysplastic Syndrome and Its Prediction of Target Genes].
2016
·
Ying Huang
, Jing Wen
, et al.
·
PubMed
·
2
[Analysis of a family with congenital dysfibrinogenemia caused by an Arg275His mutation in the gamma chain of fibrinogen].
2016
·
Jie Yan
, Donghong Deng
, et al.
·
PubMed
·
2
[Expression and Function of miR-99a-5p in Bone Marrow of Patients with MDS].
2019
·
Ying LE
, Xu-Pai Zhang
, et al.
·
PubMed
·
1
[Advances in Pathogenesis and Related Clinical Research of Thromboembolism in Patients with Thalassemia after Splenectomy].
2016
·
Na Sun
, Peng Cheng
, et al.
·
PubMed
·
1
Comprehensive Genetic Analysis of Hemophilia A in a Chinese Cohort: Insights from Next-Generation and Long-Read Sequencing
2026
·
Yuling Xu
, Xianli Qin
, et al.
·
Turkish Journal of Hematology
PDF
Clinical profiling and outcomes of ischaemic stroke patients with immune thrombocytopenia: A multicentre retrospective study
2026
·
LiQin Cao
, Jin Wu
, et al.
·
British Journal of Haematology
A novel fibrinogen gamma-chain mutation, p. γAla327Val, causes structural abnormality of D region and ultimately leads to congenital dysfibrinogenemia
2020
·
Aiqiu Wei
, Yangyang Wu
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Show more works
View as search
Works count:
32
Citation count:
382
H-index:
10
I10-index:
11
Year
Topic
Type